Brief: Aquestive Therapeutics And Intelgenx Partner With Leading Men's Health Company To Market Tadalafil Oral Films In U.S.
Sept 29 (Reuters) - Aquestive Therapeutics Inc AQST.O :
* INTELGENX AND AQUESTIVE THERAPEUTICS PARTNER WITH LEADING
MEN'S
HEALTH COMPANY TO MARKET TADALAFIL ORAL FILMS IN U.S.
Source text for Eikon: ID:nGNXCYfV5
Further company coverage: AQST.O
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA